A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study

NCT02205476 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped B5301001 study did not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.

Conditions

Hypertrophic Scars Resulting From Prior Breast Scar Revision Surgery

Interventions

DRUG: PF-06473871
DRUG: PF-06473871

Sponsor

Pfizer